All lobbying filings

RICCHETTI INCORPORATED

Lobbying for IPSEN BIOPHARMACEUTICALS, INC. · Biopharmaceutical company

Filing 2nd Quarter - Termination

2nd Quarter (Apr 1 - June 30) 2025 · Massachusetts · House · Senate · $20,000.00 income · posted Jul 21, 2025

Official filing document

Bills named in this filing 2

HR 842
Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act
S 339
Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act

Lobbying activity 2

Pharmacy

Issues related to pharmaceutical industry, generally; Issues related to development of products to treat limb spasticity and fibrodysplasia ossificans progressiva (FOP)

Medicare/Medicaid

Issues related to coverage of diagnostic testing for cancer; H.R.842/S.339, Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.